UN Photo/Christopher Black Events | 29 January 2019 MSF statements at WHO Executive Board 144th session UN Photo/Christopher Black UN Photo/Christopher Black MSF representatives are attending the 144th session of the WHO executive board meetings and will be speaking on a number of topics. Our statements Statement | 31 January 2019 Antimicrobial resistance 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min Read, watch, share Filter by - Any -EventsIssue briefLetterPress releaseSpeechStatement Statement | 24 January 2018 Tropical & neglected diseases 142nd WHO EB Agenda item 4.1 - Global snakebite burden statement Statement | 24 January 2018 Tuberculosis 142nd WHO EB Agenda item 3.9 - Preparation for a high-level meeting of the General Assembly on ending tuberculosis Statement | 24 January 2018 Intellectual property and trade Research and development 142nd WHO EB Agenda item 3.7 - Global strategy and plan of action on public health, innovation and intellectual property Statement | 24 January 2018 Vaccines 142nd WHO EB Agenda item 3.6 - Addressing the global shortage of, and access to, medicines and vaccines Load More
Statement | 31 January 2019 Antimicrobial resistance 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min
Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min
Statement | 24 January 2018 Tropical & neglected diseases 142nd WHO EB Agenda item 4.1 - Global snakebite burden statement
Statement | 24 January 2018 Tuberculosis 142nd WHO EB Agenda item 3.9 - Preparation for a high-level meeting of the General Assembly on ending tuberculosis
Statement | 24 January 2018 Intellectual property and trade Research and development 142nd WHO EB Agenda item 3.7 - Global strategy and plan of action on public health, innovation and intellectual property
Statement | 24 January 2018 Vaccines 142nd WHO EB Agenda item 3.6 - Addressing the global shortage of, and access to, medicines and vaccines
